Table 1 The basic characteristics of PCOS women in this trial
Study group (HMG + MPA + CC; n = 110) | Control group (HMG + MPA; n = 110) | |
|---|---|---|
Age (y) | 30.5 ± 3.7 | 30.6 ± 3.4 |
Duration of infertility (y), | 3.5 ± 2.6 | 3.9 ± 2.3 |
BMI (kg/m2) n (%) | ||
19~ 24.9 | 80(72.7%) | 81(73.6%) |
25~ 29.9 | 25(22.7%) | 24(21.8%) |
> =30 | 5(4.5%) | 5(4.5%) |
Previous IVF failures, n(%) | ||
0 | 89(80.9%) | 88(80.8%) |
1–3 | 21(19.1%) | 22(19.2%) |
Indication for IVF n (%) | ||
PCOS only | 27(24.5%) | 30(27.3%) |
PCOS+ male factor | 21(19.1%) | 25(22.7%) |
PCOS+ tubal factor | 52(52.7%) | 49(44.5%) |
PCOS+ other | 4(3.6%) | 6(5.5%) |
Menstrual cycle n (%) | ||
Regular | 3(2.1%) | 3(2.7%) |
Oligomenorrhea | 82(74.5%) | 91(82.7%) |
Amenorrhea | 25(22.7%) | 16(14.5%) |
Antral follicle counts | 17.9 ± 6.3 | 18.8 ± 7.1 |
Baseline hormones | ||
FSH (mIU/ml) | 4.94 ± 1.10 | 5.0 ± 1.17 |
LH (mIU/ml) | 5.03 ± 3.18 | 5.61 ± 3.36 |
E2(pg/ml) | 32.54 ± 10.34 | 30.32 ± 12.52 |
P(ng/ml) | 0.26 ± 0.19 | 0.27 ± 0.19 |
T (ng/ml) | 0.35 ± 0.13 | 0.40 ± 0.19 |